Wells Fargo & Company Forte Biosciences, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

Shares

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 10, 2024	BUY	$0.48 - $0.85 $2 - $4	5 Added 2.02%	253 $0
Q4 2023 Feb 09, 2024	BUY	$0.38 - $0.82 $4 - $10	13 Added 5.53%	248 $0
Q3 2023 Nov 13, 2023	BUY	$0.65 - $1.04 $63 - $100	97 Added 70.29%	235 $0
Q2 2023 Aug 15, 2023	BUY	$0.98 - $1.11 $5 - $6	6 Added 4.55%	138 $0
Q1 2023 May 12, 2023	BUY	$0.98 - $1.06 $5 - $6	6 Added 4.76%	132 $0
Q4 2022 Feb 13, 2023	BUY	$0.96 - $28.0 $35 - $1,036	37 Added 41.57%	126 $0
Q3 2022 Nov 14, 2022	BUY	$1.06 - $27.75 $12 - $333	12 Added 15.58%	89 $0
Q2 2022 Aug 12, 2022	SELL	$1.07 - $1.55 $45,482 - $65,885	-42,507 Reduced 99.82%	77 $0
Q1 2022 May 16, 2022	BUY	$1.21 - $2.24 $42,734 - $79,112	35,318 Added 486.07%	42,584 $62,000
Q4 2021 Feb 14, 2022	SELL	$2.02 - $3.36 $10,544 - $17,539	-5,220 Reduced 41.81%	7,266 $16,000
Q3 2021 Nov 15, 2021	SELL	$2.96 - $36.67 $17,464 - $216,353	-5,900 Reduced 32.09%	12,486 $36,000
Q2 2021 Aug 16, 2021	BUY	$31.5 - $42.5 $577,080 - $778,600	18,320 Added 27757.58%	18,386 $619,000
Q1 2021 May 13, 2021	SELL	$25.01 - $40.24 $156,312 - $251,500	-6,250 Reduced 98.96%	66 $2,000
Q4 2020 Feb 09, 2021	BUY	$28.66 - $46.79 $179,468 - $292,998	6,262 Added 11596.3%	6,316 $230,000
Q3 2020 Nov 05, 2020	BUY	$14.71 - $50.69 $294 - $1,013	20 Added 58.82%	54 $3,000
Q2 2020 Aug 13, 2020	BUY	$13.9 - $24.6 $472 - $836	34 New	34 $0

Others Institutions Holding FBRX

# of Institutions

33

Shares Held

19M

Call Options Held

3.1K

Put Options Held

0

Tybourne Capital Management (Hk) LTD Hong Kong, K3

3.62M
Shares

$18.5 Million
0.49% of portfolio
Perceptive Advisors LLC New York, NY

3.27M
Shares

$16.7 Million
0.05% of portfolio
Bvf Inc San Francisco, CA

2.98M
Shares

$15.2 Million
0.05% of portfolio
Cable Car Capital LLC San Francisco, CA

2.03M
Shares

$10.4 Million
1.15% of portfolio
Fred Alger Management, LLC New York, NY

1.84M
Shares

$9.38 Million
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $104M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.